China’s NDRC, acting through its Office of the Working Mechanism for Security Review of Foreign Investment, prohibited Meta Platforms from completing its planned acquisition of Manus, a general-purpose AI agent startup capable of autonomous coding and research tasks. According to reporting by AP and Reuters, the NDRC ordered all parties to withdraw from the deal. The transaction was reportedly valued at approximately $2 billion, though that figure has not been confirmed in any official filing.
The NDRC did not disclose the specific criteria it applied. Analysts and press reporting suggest export control and technology transfer concerns are likely factors, consistent with China’s NSR framework for advanced technology sectors, but this has not been confirmed in any official statement. Meta has not issued a public response as of this publication date.
The jurisdictional basis for the ruling is the detail compliance teams will be studying. Manus is headquartered in Singapore, not China. According to reporting by Greenwich Time, the startup traces its origins to Beijing-registered entities, a connection that reportedly triggered Chinese regulatory jurisdiction regardless of formal domicile. This is the mechanism: China’s NSR framework does not require a company to be incorporated in China to fall within its review authority. Founding entity registration is enough.
That matters well beyond this deal. The AI M&A pipeline is filled with startups founded by teams with Chinese institutional backgrounds who later relocated to Singapore, the UAE, the UK, or the US. If the NDRC’s action here reflects a consistent application of NSR authority, and the framework’s language supports that it does, Singapore incorporation is not a structural safeguard for cross-border acquisitions involving Chinese-origin founding teams.
The broader pattern is visible across multiple cycles. China has been tightening its regulatory grip on outbound AI-related transactions in parallel with US export control expansion. This action falls on the same week that US chip export rules remain in flux, a reminder that the regulatory compression on AI M&A is coming from both directions simultaneously.
What to watch: whether Meta pursues any appeal or restructuring of the deal; whether the NDRC publishes any elaboration of the criteria applied (it has not historically done so); and whether other pending cross-border AI acquisitions involving Chinese-origin founding entities are now under informal review. The absence of a Meta statement is itself a signal, acquisitions this size do not go quiet without legal counsel advising caution.
The compliance implication worth noting: due diligence frameworks for AI M&A have generally focused on the target company’s current jurisdiction, IP ownership, and data practices. This ruling suggests that founding entity provenance, who incorporated what, where, and when, before the current corporate structure existed, now belongs in the standard diligence checklist for any deal involving Chinese-origin AI assets.